Menu
Log in
Forgot password
Log in
Forgot password

News

Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma

07 Feb 2022 8:30 PM | Michele O'Bright (Administrator)
Yuichiro Doki, M.D., Jaffer A. Ajani, M.D., Ken Kato, M.D., Ph.D., Jianming Xu, M.D., Lucjan Wyrwicz, M.D., Satoru Motoyama, M.D., Ph.D., Takashi Ogata, M.D., Ph.D., Hisato Kawakami, M.D., Ph.D., Chih-Hung Hsu, M.D., Ph.D., Antoine Adenis, M.D., Ph.D., Farid El Hajbi, M.D., Maria Di Bartolomeo, M.D., et al., for the CheckMate 648 Trial Investigators*

    Read Abstract:  Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma

    Affiliated Societies



    International  Interdisciplinary  Everything Esophageal


    The International Society for Diseases of the Esophagus is a 501(c)3 non-profit organization. © International Society for Disease of the Esophagus – ISDE 2024 | Any unauthorized use or reproduction of the content is prohibited without explicit permission.

    General Inquiries: info@isde.net
    Membership Questions: membership@isde.net

    Powered by Wild Apricot Membership Software